Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000259673

Medchemexpress LLC Act-1004-1239 | 2178049-58-4 | 98.8% | C27H28F2N6O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY14261710MG

Encompass_Preferred

ACT-1004-1239 is a potent, selective, orally available CXCR7 (ACKR3) antagonist developed as a first-in-class compound. It exhibits low nanomolar potency and has shown immunomodulatory and promyelinating effects in preclinical models and early clinical research.

  • Potent CXCR7 antagonism with IC50 3.2 nM.
  • Orally bioavailable compound suitable for systemic dosing.
  • Demonstrated immunomodulatory and promyelinating activity in vivo.
  • High chemical purity and solid, stable formulation for storage.
  • Compatible with in vitro and in vivo pharmacology studies.
  • Recommended storage: powder -20°C (3 years) or 4°C (2 years).

Catalog No. 50-002-59673


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.